OptiBiotix Health (LON:OPTI) Shares Cross Below 50-Day Moving Average – Should You Sell?

Posted by Francis Steltz on Aug 21st, 2026

OptiBiotix Health Plc (LON:OPTI – Get Free Report) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 5.95 and traded as low as GBX 5.50. OptiBiotix Health shares last traded at GBX 5.50, with a volume of 189 shares trading hands.

OptiBiotix Health Price Performance

The company has a 50 day moving average of GBX 5.94 and a two-hundred day moving average of GBX 5.85. The company has a market capitalization of £5.82 million, a PE ratio of -1.47 and a beta of 1.82.

OptiBiotix Health (LON:OPTI – Get Free Report) last announced its quarterly earnings data on Thursday, May 28th. The company reported GBX (3.84) EPS for the quarter. OptiBiotix Health had a negative net margin of 333.62% and a negative return on equity of 52.92%. The firm had revenue of GBX 117 million for the quarter.

Insider Transactions at OptiBiotix Health

In other OptiBiotix Health news, insider David Blain purchased 158,965 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was bought at an average cost of GBX 6 per share, with a total value of £9,537.90. 26.79% of the stock is currently owned by company insiders.

OptiBiotix Health Company Profile

(Get Free Report)

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.